Merit Medical Systems (MMSI) Liabilities and Shareholders Equity (2010 - 2026)

Merit Medical Systems has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $2.9 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 10.73% year-over-year to $2.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.9 billion (up 10.65% YoY) and the FY2025 annual result came in at $2.7 billion, up 11.05% from the prior year.
• Liabilities and Shareholders Equity advanced to $2.9 billion in Q2 2026 per MMSI's latest filing, from $2.7 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.9 billion in Q2 2026 and troughed at $1.6 billion in Q1 2022.
• A 5-year average of $2.2 billion and a median of $2.3 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity decreased 1.33% in 2022, then surged 39.74% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then surged by 39.74% to $2.3 billion in 2023, then rose by 4.02% to $2.4 billion in 2024, then grew by 11.05% to $2.7 billion in 2025, then rose by 6.62% to $2.9 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.9 billion, $2.7 billion, and $2.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.